高雄醫學大學圖書館 |

Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids // Rishabh Bahl.
作者:	Bahl, Rishabh,
面頁冊數:	1 electronic resource (239 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-07, Section: B.
提要註:	Pancreatic cancer is one of the deadliest cancers to treat. The primary cause for the drug resistance is the dense extracellular matrix (ECM) that surrounds the tumor and restricts blood supply. Gemcitabine (GEM) and paclitaxel (PTX) are drugs that are clinically used in the treatment of pancreatic cancer. GEM, however, is rapidly metabolized by cytidine deaminase (CDA) and eliminated from the body, and paclitaxel is a substrate for P-glycoprotein (P-gp) efflux receptors. Drug delivery using nanoparticles has been reported to help improve drug half-lives and bypass efflux receptors. This thesis aims to encapsulate PTX in PLGA nanoparticles (PTX-NP) and evaluate it along with GEM and stearoyl gemcitabine (St.GEM) in monolayer cell cultures and desmoplastic 3D coculture model, with a focus on the responsiveness of the ECM. We also aim to understand the effects of PTX-NP by correlating drug release, toxicity, and cellular pharmacokinetic profiles with the PTX-NP's degradation data. Lastly, we aim to evaluate our collaborators pH sensitive polymersomes in the co-cultures.PTX-NP had a particle size of ~242nm and an encapsulation efficiency of ~92%, an incomplete drug release in non-sink conditions and burst release under sink conditions. Cytotoxicity was highest for PTX-NP, followed by PTX, St.GEM and GEM. Except in BxPC-3 cells, synergy was seen when PTX or PTX-NP were dosed first followed by GEM or St.GEM. GEM's cytotoxicity was independent of CDA expression. In 3D cultures, PTX and PTX-NP resulted in debris formation from the spheroids. The ECM was found to be responsive to therapy, with collagen showing a rise and fall in response to increasing GEM concentrations. Fibronectin seemed most susceptible with a consistent fall in intensity with rising drug concentration. Cellular pharmacokinetics was evaluated for PTX and showed a mass balance between unabsorbed extracellular and absorbed intracellular concentration, indicating P-gp involvement is unlikely. In spheroids, PTX-NP shows efficacy despite incomplete drug release. The pH sensitive polymersomes exhibited dose dependent toxicity to the spheroids. Overall, our findings demonstrate ECM sensitivity and call for more work exploring the feasibility of fibronectin as a future drug target to examine its potential in treating pancreatic cancer.
Contained By:	Dissertations Abstracts International85-07B.
標題:	Nanoscience. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30988717
ISBN:	9798381418330

Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids /
Bahl, Rishabh,

Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids /Rishabh Bahl. - 1 electronic resource (239 pages)

Source: Dissertations Abstracts International, Volume: 85-07, Section: B.

Pancreatic cancer is one of the deadliest cancers to treat. The primary cause for the drug resistance is the dense extracellular matrix (ECM) that surrounds the tumor and restricts blood supply. Gemcitabine (GEM) and paclitaxel (PTX) are drugs that are clinically used in the treatment of pancreatic cancer. GEM, however, is rapidly metabolized by cytidine deaminase (CDA) and eliminated from the body, and paclitaxel is a substrate for P-glycoprotein (P-gp) efflux receptors. Drug delivery using nanoparticles has been reported to help improve drug half-lives and bypass efflux receptors. This thesis aims to encapsulate PTX in PLGA nanoparticles (PTX-NP) and evaluate it along with GEM and stearoyl gemcitabine (St.GEM) in monolayer cell cultures and desmoplastic 3D coculture model, with a focus on the responsiveness of the ECM. We also aim to understand the effects of PTX-NP by correlating drug release, toxicity, and cellular pharmacokinetic profiles with the PTX-NP's degradation data. Lastly, we aim to evaluate our collaborators pH sensitive polymersomes in the co-cultures.PTX-NP had a particle size of ~242nm and an encapsulation efficiency of ~92%, an incomplete drug release in non-sink conditions and burst release under sink conditions. Cytotoxicity was highest for PTX-NP, followed by PTX, St.GEM and GEM. Except in BxPC-3 cells, synergy was seen when PTX or PTX-NP were dosed first followed by GEM or St.GEM. GEM's cytotoxicity was independent of CDA expression. In 3D cultures, PTX and PTX-NP resulted in debris formation from the spheroids. The ECM was found to be responsive to therapy, with collagen showing a rise and fall in response to increasing GEM concentrations. Fibronectin seemed most susceptible with a consistent fall in intensity with rising drug concentration. Cellular pharmacokinetics was evaluated for PTX and showed a mass balance between unabsorbed extracellular and absorbed intracellular concentration, indicating P-gp involvement is unlikely. In spheroids, PTX-NP shows efficacy despite incomplete drug release. The pH sensitive polymersomes exhibited dose dependent toxicity to the spheroids. Overall, our findings demonstrate ECM sensitivity and call for more work exploring the feasibility of fibronectin as a future drug target to examine its potential in treating pancreatic cancer.

English

ISBN: 9798381418330Subjects--Topical Terms:

232829
Nanoscience.
Subjects--Index Terms:

Extracellular matrix

Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids /
LDR:03952nam a22004453i 4500 001 391399
005 20251124054751.5
006 m o d
007 cr|nu||||||||
008 251208s2024 miu||||||m |||||||eng d
020 $a 9798381418330
035 $a (MiAaPQD)AAI30988717
035 $a AAI30988717
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Bahl, Rishabh, $e author. $3 523828
245 1 0 $a Delivery of Gemcitabine, Stearoyl Gemcitabine and Paclitaxel Through PLGA Nanoparticles and Its Effect on the Desmoplasia of Pancreatic Cancer Spheroids / $c Rishabh Bahl.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 1 electronic resource (239 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-07, Section: B.
500 $a Advisors: Reineke, Joshua Committee members: Perumal, Omathanu; Gunaje, Jayarama; Millett, Bruce; Wood, Scott.
502 $b Ph.D. $c South Dakota State University $d 2024.
520 $a Pancreatic cancer is one of the deadliest cancers to treat. The primary cause for the drug resistance is the dense extracellular matrix (ECM) that surrounds the tumor and restricts blood supply. Gemcitabine (GEM) and paclitaxel (PTX) are drugs that are clinically used in the treatment of pancreatic cancer. GEM, however, is rapidly metabolized by cytidine deaminase (CDA) and eliminated from the body, and paclitaxel is a substrate for P-glycoprotein (P-gp) efflux receptors. Drug delivery using nanoparticles has been reported to help improve drug half-lives and bypass efflux receptors. This thesis aims to encapsulate PTX in PLGA nanoparticles (PTX-NP) and evaluate it along with GEM and stearoyl gemcitabine (St.GEM) in monolayer cell cultures and desmoplastic 3D coculture model, with a focus on the responsiveness of the ECM. We also aim to understand the effects of PTX-NP by correlating drug release, toxicity, and cellular pharmacokinetic profiles with the PTX-NP's degradation data. Lastly, we aim to evaluate our collaborators pH sensitive polymersomes in the co-cultures.PTX-NP had a particle size of ~242nm and an encapsulation efficiency of ~92%, an incomplete drug release in non-sink conditions and burst release under sink conditions. Cytotoxicity was highest for PTX-NP, followed by PTX, St.GEM and GEM. Except in BxPC-3 cells, synergy was seen when PTX or PTX-NP were dosed first followed by GEM or St.GEM. GEM's cytotoxicity was independent of CDA expression. In 3D cultures, PTX and PTX-NP resulted in debris formation from the spheroids. The ECM was found to be responsive to therapy, with collagen showing a rise and fall in response to increasing GEM concentrations. Fibronectin seemed most susceptible with a consistent fall in intensity with rising drug concentration. Cellular pharmacokinetics was evaluated for PTX and showed a mass balance between unabsorbed extracellular and absorbed intracellular concentration, indicating P-gp involvement is unlikely. In spheroids, PTX-NP shows efficacy despite incomplete drug release. The pH sensitive polymersomes exhibited dose dependent toxicity to the spheroids. Overall, our findings demonstrate ECM sensitivity and call for more work exploring the feasibility of fibronectin as a future drug target to examine its potential in treating pancreatic cancer.
546 $a English
590 $a School code: 0205
650 4 $2 96060 $a Nanoscience. $3 232829
650 4 $2 96060 $a Oncology. $3 273823
650 4 $a Pharmaceutical sciences. $3 523812
653 $a Extracellular matrix
653 $a Nanoparticle
653 $a Pancreatic cancer
653 $a Pharmacokinetics
653 $a Spheroids multicellular
653 $a Drug delivery system
690 $a 0572
690 $a 0565
690 $a 0992
710 2 $a South Dakota State University. $b Pharmaceutical Sciences. $e degree granting institution. $3 523829
720 1 $a Reineke, Joshua $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 85-07B.
790 $a 0205
791 $a Ph.D.
792 $a 2024
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30988717